Ticagrelor vs. clopidogrel for coronary microvascular dysfunction in patients with STEMI: a meta-analysis of randomized controlled trials.

Yike Li,Zixiang Ye,Ziyu Guo,Enmin Xie, Min Wang,Xuecheng Zhao, Mei Liu,Peizhao Li,Changan Yu,Yanxiang Gao,Jingang Zheng

Frontiers in cardiovascular medicine（2023）

引用 0|浏览1

暂无评分

摘要

Ticagrelor has more benefits for coronary microcirculation than clopidogrel in STEMI patients who undergo the primary percutaneous coronary intervention. However, recommendations for which P2Y12 receptor inhibitor should be used in STEMI patients should be provided according to results of studies that investigate clinical outcomes.

查看译文

关键词

ST-elevation myocardial infarction,ticagrelor,clopidogrel,coronary microcirculation dysfunction,meta-analysis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要